Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Share-based Compensation (2020 - 2025)

BioAtla (BCAB) has 6 years of Share-based Compensation data on record, last reported at $1.3 million in Q3 2025.

  • For Q3 2025, Share-based Compensation fell 41.11% year-over-year to $1.3 million; the TTM value through Sep 2025 reached $6.2 million, down 35.8%, while the annual FY2024 figure was $8.9 million, 34.13% down from the prior year.
  • Share-based Compensation reached $1.3 million in Q3 2025 per BCAB's latest filing, down from $1.4 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $12.3 million in Q2 2021 and bottomed at $1.3 million in Q3 2025.
  • Average Share-based Compensation over 5 years is $3.5 million, with a median of $3.5 million recorded in 2023.
  • Peak YoY movement for Share-based Compensation: surged 155.6% in 2021, then plummeted 68.76% in 2022.
  • A 5-year view of Share-based Compensation shows it stood at $3.8 million in 2021, then dropped by 8.11% to $3.5 million in 2022, then dropped by 21.79% to $2.7 million in 2023, then fell by 29.47% to $1.9 million in 2024, then crashed by 33.09% to $1.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $1.3 million in Q3 2025, $1.4 million in Q2 2025, and $1.6 million in Q1 2025.